1. Home
  2. MBWM vs SYRE Comparison

MBWM vs SYRE Comparison

Compare MBWM & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBWM
  • SYRE
  • Stock Information
  • Founded
  • MBWM 1997
  • SYRE 2013
  • Country
  • MBWM United States
  • SYRE United States
  • Employees
  • MBWM N/A
  • SYRE N/A
  • Industry
  • MBWM Major Banks
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBWM Finance
  • SYRE Health Care
  • Exchange
  • MBWM Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • MBWM 704.2M
  • SYRE 841.4M
  • IPO Year
  • MBWM 1997
  • SYRE 2016
  • Fundamental
  • Price
  • MBWM $43.76
  • SYRE $14.10
  • Analyst Decision
  • MBWM Buy
  • SYRE Buy
  • Analyst Count
  • MBWM 2
  • SYRE 8
  • Target Price
  • MBWM $52.25
  • SYRE $50.00
  • AVG Volume (30 Days)
  • MBWM 47.6K
  • SYRE 553.9K
  • Earning Date
  • MBWM 04-22-2025
  • SYRE 05-08-2025
  • Dividend Yield
  • MBWM 3.36%
  • SYRE N/A
  • EPS Growth
  • MBWM N/A
  • SYRE N/A
  • EPS
  • MBWM 4.80
  • SYRE N/A
  • Revenue
  • MBWM $222,296,000.00
  • SYRE N/A
  • Revenue This Year
  • MBWM $8.87
  • SYRE N/A
  • Revenue Next Year
  • MBWM $3.71
  • SYRE N/A
  • P/E Ratio
  • MBWM $9.18
  • SYRE N/A
  • Revenue Growth
  • MBWM 0.96
  • SYRE N/A
  • 52 Week Low
  • MBWM $35.61
  • SYRE $10.91
  • 52 Week High
  • MBWM $52.98
  • SYRE $40.49
  • Technical
  • Relative Strength Index (RSI)
  • MBWM 58.15
  • SYRE 48.32
  • Support Level
  • MBWM $42.24
  • SYRE $12.29
  • Resistance Level
  • MBWM $44.08
  • SYRE $15.77
  • Average True Range (ATR)
  • MBWM 1.26
  • SYRE 1.06
  • MACD
  • MBWM 0.37
  • SYRE 0.08
  • Stochastic Oscillator
  • MBWM 86.86
  • SYRE 52.08

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It provides a variety of commercial banking services to individuals, businesses, governmental units, and other institutions. It provides banking services offering deposit products including checking, savings, and term certificate accounts, and lending products including commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: